2型糖尿病合并非酒精性脂肪性肝病的代谢相关危险因素分析 (1)

2型糖尿病合并非酒精性脂肪性肝病的代谢相关危险因素分析

作者：郭敏， 郗光霞， 杨娜， 姚红， Guo Min， Xi Guangxia， Yang Na， Yao Hong

作者单位：郭敏,杨娜,姚红,Guo Min,Yang Na,Yao Hong(山西医科大学第二临床医学院内分泌科,太原,030001)， 郗光霞,Xi Guangxia(山西医学科学院山西大医院内分泌科)

刊名：

中华肝脏病杂志

英文刊名：Chinese Journal of Hepatology

年，卷(期)：2014,22(8)

被引用次数：5次

1.Fan JG,Farrell GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol,2009,50:204-210. 2009

2.zhang HF,Chi JM,Wang RP.Practical diabetes[M].2version.Beijing:People's Medical Publishing House,2001:159-171.张慧芬,迟家敏,王瑞萍.实用糖尿病学[M].2版.北京:人民卫生出版社,2001:159-171. 2001

3.zhang HF,Chi JM,Wang RP.Practical diabetes[M].2version.Beijing:People's Medical Publishing House,2001:159-171.张慧芬,迟家敏,王瑞萍.实用糖尿病学[M].2版.北京:人民卫生出版社,2001:159-171. 2001

4.The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology of Chinese Medical Association.Guidelines for management of nonalcoholic fatty liverdisease:an updated and revised

edition[J].Chin J Hepatol,2010,18:163-166.(in Chinese) 2010

5.中华医学会肝病学分会脂肪肝和酒精性肝病学组非酒精性脂肪性肝病诊疗指南（2010年修订版）[期刊论文]-中华肝脏病杂志2010(03)

6.Li X,Zhou ZG,Qi HY,et al.Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet β cell function[J].J Cent South Univ (Med Sci),2004,29:419-423.(in Chinese)李霞,周智广,亓海英,等.用空腹C肽代替胰岛素改良HOMA公式评价胰岛素抵抗和胰岛B细胞功能[J].中南大学学报(医学版),2004,29:419-423. 2004

7.Matsuda M,DeFronzo RA.Insulin sensitivity indices obtained from oral glucose tolerance testing:comparison with the euglycemic insulin clamp[J].Diabetes Care,1999,22:1462-1470. 1999

8.Li GW.Re-recognition of islet beta cell function evaluation[J].Section Endocrinol Foreign Med Sci,2005,25:164-166.李光伟.对胰岛β细胞功能评估的再认识[J].国外医学内分泌学分册,2005,25:164-166. 2005

9.李光伟对胰岛β细胞功能评估的再认识[期刊论文]-国外医学(内分泌学分册) 2005(03)

10.G】o)nbaek H,Thomsen KL,Rungby J,et al.Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes[J].Expert Rev Gastroenterol Hepatol,2008,2:705-711. 2008

11.Lonardo A.Fatty liver and nonalcoholic steatohepatitis.Where do we stand and where are we going?[J].Dig

Dis,1999,17:80-89. 1999

12.Williams CD,Stengel J,Asike MI,et al.Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy:a prospective

study[J].Gastroenterology,2011,140:124-131. 2011

13.Targher G,Bertolini L,Padovani R,et al.Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients[J].Diabetes Care,2007,30:1212-1218. 2007

14.Pirgon O,Bilgin H,Tolu I,et al.Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease[J].Clin Endocrinol (Oxf),2011,75:189-195. 2011

15.Liang XG,Zhou T,Gao JD.Analysis of clinical data on nonalcoholic fatty liver disease in patients with type 2 diabetes[J].China Health Innov,2008,3:34-35.(in Chinese) 梁晓刚,周涛,高继东.2型糖尿病合并非酒精性脂肪肝临床资料分析[J].中国医疗前沿,2008,3:34-35. 2008

16.Xin HH,Xi GX,Chen Y,et al.Different pancreatic islet β cell function index for the evaluation of glucose metabolism in type 2 diabetes[J].China J Postgrad Med,2012,35:13-15.(in Chinese) 辛欢欢,郗光霞,陈瑶,等.不同胰岛β细